|
BSE
Announcements
|
|
Aruna Hotels
|
|
Aruna Hotels Limited will hold a meeting of its Board of Directors on August 12, 2026, to consider and approve the standalone unaudited financial results for the quarter ended June 30, 2026, according to a filing with the BSE Limited. The trading window for designated persons will remain closed from July 1, 2026, and will reopen 48 hours after the financial results are declared.
|
|
Asian Hotels (N)
|
|
Asian Hotels (North) Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a filing with the BSE Ltd. and National Stock Exchange of India Ltd. The trading window for the company's securities will reopen 48 hours after the declaration of the financial results, following a closure that began on July 1, 2026.
|
|
Astrazeneca Phar
|
|
AstraZeneca Pharma India Limited will hold a board meeting on Monday, August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for designated persons will remain closed from June 16, 2026, to August 12, 2026, in accordance with the company’s insider trading code.
|
|
Atlas Cycles
|
|
Atlas Cycles (Haryana) Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing to the National Stock Exchange of India Ltd. and BSE Ltd.
|
|
BASF India
|
|
BASF India Limited announced that its board of directors approved the closure of sulfation & low temperature reactor plants related to its Care Chemicals business at the Dahej manufacturing site, expected by the end of calendar year 2026, due to changing competitive landscape and margin pressure. The Care Chemicals business at Dahej, part of the Nutrition & Care Segment, contributed revenues of Rs 542 crore, representing 4% of the company’s total revenues during the financial year 2025-26.
|
|
Abbott India
|
|
Abbott India Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing. The company’s trading window will remain closed from Wednesday, July 1, 2026, to Friday, August 14, 2026, inclusive.
|
|
Citurgia Biochem
|
|
Citurgia Biochemicals Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited.
|
|
DCM
|
|
DCM Limited will hold a meeting of its Board of Directors on August 13, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ending June 30, 2026, according to a regulatory filing. The trading window for equity shares of DCM Limited will remain closed until August 15, 2026.
|
|
Fermenta Biotec.
|
|
Fermenta Biotech Limited will hold a board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, both standalone and consolidated, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. Trading in the company’s securities will be closed for directors, promoters, insiders, designated persons, their immediate relatives, auditors, and other connected persons from July 1, 2026, until 48 hours after the financial results are declared.
|
|
EPL Ltd
|
|
EPL Limited will hold a board meeting on Tuesday, August 11, 2026, to consider the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, and the trading window for listed securities will reopen 48 hours after the results are declared.
|